Ignite Creation Date:
2025-12-25 @ 1:16 AM
Ignite Modification Date:
2026-01-01 @ 10:46 AM
Study NCT ID:
NCT01399593
Status:
TERMINATED
Last Update Posted:
2017-10-03
First Post:
2011-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-11-02
Start Date Type:
ACTUAL
Primary Completion Date:
2014-05-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-11-13
Completion Date Type:
ACTUAL
First Submit Date:
2011-07-19
First Submit QC Date:
None
Study First Post Date:
2011-07-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-09
Results First Submit QC Date:
None
Results First Post Date:
2017-04-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-11-21
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-09-04
Last Update Post Date:
2017-10-03
Last Update Post Date Type:
ACTUAL